Join
Live feed
·
INSIDERFilingvia Quantisnow
Atrium Therapeutics Inc. logo

Chief Program Officer Gallagher Kathleen P. exercised 5,875 shares at a strike of $16.65 and sold $190,833 worth of shares (5,875 units at $32.48) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
RNA· Atrium Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RNA (Atrium Therapeutics Inc.) and more on Quantisnow.